Going-concern / business failure risk
The company disclosed limited cash and a working-capital deficiency, making continued operations dependent on new funding.
- Scope
- Corporate liquidity and all operating subsidiaries
- Materiality
- high
Kaya Holdings, Inc. is a U.S.-based cannabis and emerging psychedelics operator that runs retail sales, cultivation-related projects, and service activities through a network of majority-owned subsidiaries. The company also has a newer digital-assets treasury initiative, but its current business remains centered on cash-and-carry cannabis retail and development-stage cannabis/psychedelic operations.
−28 261,1 %
−5,1 %
−29 168,2 %
−96,4 %
0.01
0.01
| % | |
|---|---|
| Cannabis retail | 70% Cash-and-carry sales of cannabis products through licensed retail locations. |
| Cannabis cultivation and processing development | 10% Development-stage cultivation, extraction, packing, and related infrastructure projects, mainly in Greece. |
| Psychedelic services | 10% OHA-licensed psilocybin service center activities and related facilitation services. |
| Licensing and pilot studies | 5% Contract-based revenue from licensing agreements and pilot studies. |
| Ancillary services | 5% ATM transaction fees and other small ancillary revenue streams at operating sites. |
Kaya sells primarily to adult-use cannabis consumers at licensed retail stores, where transactions are completed...
Buy cannabis products at licensed stores on a cash-and-carry basis for immediate consumption or use.
Buy cultivation, extraction, and processing output from the company's overseas cannabis platform as it develops.
Purchase regulated psilocybin facilitation services at the company's licensed service center.
Enter contracts for product commercialization, licensing, or pilot studies tied to the company's development pipeline.
Provide ancillary fee income from ATM transactions at retail locations.
Kaya is headquartered in the United States and operates mainly through Florida, Oregon, and other U.S...
Management is trying to fund and complete its growth projects while sustaining current retail operations and preserving...
The company needs financing to fund operations, complete projects, and bridge working-capital deficits.
The Epidaurus site could add cultivation, extraction, and packing capacity if financed and completed.
This creates a second regulated healthcare-adjacent growth avenue beyond cannabis retail.
Management is adding new platforms to reduce dependence on a narrow retail base.
Kaya faces substantial going-concern, financing, and execution risk because it has limited cash, a working-capital...
The company disclosed limited cash and a working-capital deficiency, making continued operations dependent on new funding.
Operations and project completion rely on future equity or debt raises, which may be unavailable or highly dilutive.
Cannabis operations are subject to changing state/federal rules and Section 280E limits on deductions.
Management cited uncertainty around product commercialization and ultimate success.
Retail cannabis markets are competitive and product pricing can be volatile, pressuring margins.
The Greece project has already been delayed by COVID-19 and the Russia/Ukraine war, showing external disruption risk.
VRNO · Agricultural Production-Crops
CBDY · Medicinal Chemicals & Botanical Products
PLNH · Agricultural Production-Crops
CNTN · Finance Services
CHUC · Medicinal Chemicals & Botanical Products
CPMD · Pharmaceutical Preparations
: 28/04/2026